Schizophrenia Clinical Trial
Official title:
STAGE 1: Investigating Attributions and Expressed Emotion in Parents With and Without Psychosis STAGE 2: Investigating the Use of a Self-directed Parenting Programme With Parents Experiencing Psychosis
The purpose of this trial is to explore parent-child interactions in parents with and without psychosis, and ascertain whether a brief (10 week) supported self-help parenting program offered to parents in their own homes can help improve parents' self-efficacy and general well-being, as well as interpretations of their parent-child relationship and child behaviour in children who are 3-10 years old.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | July 2017 |
Est. primary completion date | July 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria for parents with psychotic illnesses 1. Presence of ICD-10 schizophrenia-spectrum diagnosis (F20-29). 2. Primary parental caregiver for index child. This includes 10 hours of contact time with their child. 3. Over 18 years of age. 4. Have at least one child aged 3-10 years old. 5. Identify difficulties in parenting during assessment. 6. Proficient in written and spoken English. 7. Capacity to provide informed consent. Exclusion Criteria for parents with psychotic illnesses 1. Parents with a schizophrenia-spectrum diagnosis who have recently been discharged from acute in-patient care, and have less than four weeks of stabilisation. This will enable the individual sufficient time to readjust to living in the community and ensure symptom stabilisation before taking part in a study. 2. Parents who have no regular contact with the index child or where there is known intention for their child to be removed. 3. Parents who present with child protection of safeguarding issues. 4. Parents seeking or receiving support from services regarding child management issues. 5. Parents actively involved in other structured programmes. Inclusion Criteria matched comparison group of parents for stage 1 The comparison group of parents will be matched for age, education, socioeconomic status and family composition where possible 1. No previous history of psychotic illnesses. 2. Primary parental caregiver for index child. This includes 10 hours of contact time with their child. 3. Over 18 years of age. 4. Have at least one child aged 3-10 years old. 5. Identify difficulties in parenting during assessment. 6. Proficient in written and spoken English. 7. Capacity to provide informed consent. Exclusion Criteria for comparison group 1. Parents with schizophrenia-spectrum symptoms, diagnosis or history. 2. Parents who have no regular contact with the index child or where there is known intention for their child to be removed. 3. Parents seeking support from services regarding child management issues. 4. Parents actively involved in other structured programmes. 5. Parents/caregivers who do not have good working knowledge of English. They should have enough practical experience to be able to adequately use the English language to understand and respond to questions and to read and complete questionnaires. 6. Insufficient language or cognitive ability to participant fully or provide informed consent. |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Country | Name | City | State |
---|---|---|---|
United Kingdom | The University of Manchester | Manchester | Lancashire |
Lead Sponsor | Collaborator |
---|---|
University of Manchester |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Positive and Negative Syndrome Scale (PANSS) | Assessment of parental symptoms, mood, behaviours, aswell as social performance and depression | Initial Ax, Multiple Baseline Ax, Final Baseline Ax, 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up | No |
Primary | Five Minute Speech Sample (FMSS) | Assessment of Expressed Emotion using a 5 minute uninterrupted interview | Initial Ax, End Ax, Follow up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up | No |
Primary | Modified Camberwell Family Interview (CFI) | In depth assessment of Expressed Emotion using a modified version of the CFI. This version is for parents of well children. | Initial Ax only | No |
Secondary | Depression, Anxiety and Stress Scale (DASS-21) | Self-reported depression, anxiety and stress using a short form scale | Initial Ax, Multiple Baseline Ax, Final Baseline Ax, 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up | No |
Secondary | Warwick-Edinburgh Mental Well-being Scale (WEMWBS) | Self-reported general well-being | Initial Ax, Final Baseline Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up | No |
Secondary | Eyberg Child Behaviour Inventory (ECBI) | Parents self-reported child problem behaviour | Initial Ax, Final Baseline Ax, 10 support sessions Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up | No |
Secondary | Strengths and Difficulties Questionnaire (SDQ) | Parents self-reported child behaviour assessing different aspects of behaviour, e.g.,: emotional symptoms, conduct problems, hyperactivity/inattention. | Initial Ax, Final Baseline Ax, End Ax, Follow Up Ax. Ax from 0 - 16 weeks with 3 and 6 month follow up | No |
Secondary | Parenting and Family Adjustment Scale (PAFAS) | An assessment of parenting skills and family relationships. | Baseline, 1, 5, 10, follow up | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |